Second-generation antipsychotic medications for children and adolescents.

This study aimed to identify the efficacy and tolerability of different antipsychotics in children and adolescents with schizophrenia or bipolar disorder. We conducted a literature review of the empirical evidence for the use of antipsychotics, particularly second-generation antipsychotics, in children and adolescents. The empirical evidence showed that antipsychotic use among children and adolescents was safe and efficacious. The efficacy of antipsychotics in the treatment of children and adolescents with schizophrenia or bipolar disorder was almost similar. When prescribing antipsychotics to children and adolescents, clinicians should consider adverse events and/or the discontinuation rate in treated patients. However, based on current evidence, it appears difficult to reach a consensus on the use of antipsychotics in children and adolescents. PMID: 32999174 [PubMed - as supplied by publisher]
Source: Journal of Nippon Medical School - Category: Universities & Medical Training Authors: Tags: J Nippon Med Sch Source Type: research